
Founded in 1972, Everlight Chemical began developing prostaglandin APIs in 1992, achieving sustainable growth by balancing economic, social and environmental responsibility alongside worker safety. Its APIs are registered worldwide, including the US, Canada, UK, EU, Japan, China, Russia, India, South America, Egypt and the Middle East, with its plant certified by Taiwan FDA, US FDA, EMEA, PMDA and Swedish MPA, and sales distributed across more than 40 countries.

暂无评论。
留下您的评分和评论